← Back to Search
Pleural Mesothelioma And Lung Cancer: The Role Of Asbestos Exposure And Genetic Variants In Selected Iron Metabolism And Inflammation Genes
F. Celsi, S. Crovella, R. R. Moura, M. Schneider, F. Vita, L. Finotto, G. Zabucchi, P. Zacchi, V. Borelli
Published 2019 · Medicine
Download PDFAnalyze on Scholarcy
ABSTRACT Two of the major cancerous diseases associated with asbestos exposure are malignant pleural mesothelioma (MPM) and lung cancer (LC). In addition to asbestos exposure, genetic factors have been suggested to be associated with asbestos-related carcinogenesis and lung genotoxicity. While genetic factors involved in the susceptibility to MPM were reported, to date the influence of individual genetic variations on asbestos-related lung cancer risk is still poorly understood. Since inflammation and disruption of iron (Fe) homeostasis are hallmarks of asbestos exposure affecting the pulmonary tissue, this study aimed at investigating the association between Fe-metabolism and inflammasome gene variants and susceptibility to develop LC or MPM, by comparing an asbestos-exposed population affected by LC with an “asbestos-resistant exposed population”. A retrospective approach similar to our previous autopsy-based pilot study was employed in a novel cohort of autoptic samples, thus giving us the possibility to corroborate previous findings obtained on MPM by repeating the analysis in a novel cohort of autoptic samples. The protective role of HEPH coding SNP was further confirmed. In addition, the two non-coding SNPs, either in FTH1 or in TF, emerged to exert a similar protective role in a new cohort of LC exposed individuals from the same geographic area of MPM subjects. No association was found between NLRP1 and NLRP3 polymorphisms with susceptibility to develop MPM and LC. Further research into a specific MPM and LC “genetic signature” may be needed to broaden our knowledge of the genetic landscape attributed to result in MPM and LC.
This paper references
Malignant mesothelioma as an oxidative stress-induced cancer: An update.
S. H. Chew (2015)
NLRP1 and NLRP3 polymorphisms in mesothelioma patients and asbestos exposed individuals a population-based autopsy study from North East Italy
V. Borelli (2015)
Iron and Iron-Related Proteins in Asbestosis.
A. Ghio (2015)
Iron signature in asbestos-induced malignant pleural mesothelioma: A population-based autopsy study
S. Crovella (2016)
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
W. Travis (2015)
A Procedure for the Isolation of Asbestos Bodies from Lung Tissue by Exploiting their Magnetic Properties: A New Approach to Asbestos Body Study
V. Borelli (2007)
RStudio: Integrated development for r. rstudio
Genetic Variants Associated with Increased Risk of Malignant Pleural Mesothelioma: A Genome-Wide Association Study
G. Matullo (2013)
Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
A. Hirvonen (1996)
Asbestos Lung Burden in Necroscopic Samples from the General Population of Milan, Italy.
M. Casali (2015)
New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.
B. Mossman (2013)
Iron overload signature in chrysotile‐induced malignant mesothelioma
L. Jiang (2012)
Genome-wide gene-asbestos exposure interaction association study identifies a common susceptibility variant on 22q13.31 associated with lung cancer
Differential expression of inflammasomes in lung cancer cell lines and tissues
H. Kong (2015)
Heme Oxygenase-1 Promoter Polymorphism is Associated with Risk of Malignant Mesothelioma
A. Murakami (2012)
Genomewide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility
S. Wei (2012)
Odds Ratios-Current Best Practice and Use.
E. Norton (2018)
RStudio: Integrated development for r
Mechanisms in the pathogenesis of asbestosis and silicosis.
B. Mossman (1998)
Incidence and clinical manifestations of cardiac metastases.
H. Bisel (1953)
Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma
M. Carbone (2011)
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes
M. Betti (2018)
Asbestos-related mesothelioma in Monfalcone, Italy.
C. Bianchi (1993)
In vitro studies on the biologic effects of fibers: correlation with in vivo bioassays.
B. Mossman (1990)
Sex chromosomes and genetic association studies
D. Clayton (2009)
Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
S. Tunesi (2015)
Cytosolic Recognition of Microbes and Pathogens: Inflammasomes in Action
Jenni A. Hayward (2018)
Asbestos Exposure, Manganese Superoxide Dismutase (MnSOD) Genotype, and Lung Cancer Risk
L. Wang (2004)
A pathology atlas of the human cancer transcriptome
M. Uhlén (2017)
This publication represents the views and expert opinions of an IARC working group on the evaluation of carcinogenic risks to humans, which met in Lyon
A method for extracting ferruginous bodies from sputum and pulmonary tissue.
M. J. Smith (1972)
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.
F. Gemignani (2009)
Morphological and Chemical Mechanisms of Elongated Mineral Particle Toxicities
A. Aust (2011)
A genome-wide association study for malignant mesothelioma risk.
G. Cadby (2013)
BAP1 and cancer
M. Carbone (2013)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
R. Bueno (2016)
Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles
P. Andujar (2016)
Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States
R. Lemen (2016)
Germline Bap1mutational landscape of asbestos-exposedmalignantmesothelioma patientswith family history of cancer.Cancer Res. 76:206–15
J. A. Ohar (2016)
International Agency for Research on Cancer.
E. Somers (1985)
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
J. Ohar (2016)
Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study.
I. Dianzani (2006)
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
M. Carbone (2019)
Introduction to genetic association studies.
H. Tsao (2007)
A genome-wide association study formalignantmesothelioma risk
G. Cadby (2013)
Asbestos-induced lung diseases: an update.
D. Kamp (2009)
Fenten chemistry of Fe(III)-exchanged zeolitic minerals treated with antioxidants.
T. A. Ruda (2005)
Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.
M. Schabath (2002)
Exploring Diallelic Genetic Markers: The HardyWeinberg Package
J. Graffelman (2015)
Exposure to asbestos in Monfalcone, Italy. A necropsy-based study.
C. Bianchi (1991)
The role of iron in Libby amphibole-induced acute lung injury and inflammation
J. Shannahan (2011)
Genome-wide gene–environment interaction analysis for asbestos exposure in lung cancer susceptibility
S. Wei (2012)
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Catherine Dostert (2008)
Smoking and the molecular epidemiology of lung cancer.
D. Christiani (2000)
NLRP1 polymorphisms in patients with asbestos-associated mesothelioma
M. Girardelli (2012)
CYP1A1 and CYP1B1 polymorphisms as modifying factors in patients with pneumoconiosis and occupationally related tumours: A pilot study.
J. Schneider (2009)
Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome.
Joyce K. Thompson (2017)
Role of Iron in the Cellular Effects of Asbestos
E. Aust (2000)
Asbestos‐associated genome‐wide DNA methylation changes in lung cancer
E. Kettunen (2017)
Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort.
S. Markowitz (2013)
A genetic variant of NLRP1 gene is associated with asbestos body burden in patients with malignant pleural mesothelioma
S. Crovella (2018)
Inflammasome Activity in Non-Microbial Lung Inflammation.
J. Ather (2014)
The molecular basis of asbestos induced lung injury
D. Kamp (1999)
Smokinginduced iron dysregulation in the lung. Free Radic
W Z Zhang (2019)
fibres, and dusts: This publication represents the views and expert opinions of an IARC working group on the evaluation of carcinogenic risks to humans, which met in Lyon, 17–24
Genome-wide Gene–Asbestos Exposure Interaction Association Study Identifies a Common Susceptibility Variant on 22q13.31 Associated with Lung Cancer Risk
C. Liu (2015)
Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses
F. Faul (2009)
Malignant mesothelioma: global incidence and relationship with asbestos.
C. Bianchi (2007)
The 2004 World Health Organization classification of lung tumors.
M. Beasley (2005)
The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.
F. Martinon (2002)
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.
M. Neri (2008)
Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
M. Betti (2017)
Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
Jedd M. Hillegass (2013)
Asbestos is not just asbestos: an unrecognised health hazard.
F. Baumann (2013)
Polymorphisms of glutathione‐S‐transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma
S. Landi (2007)
Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California.
S. London (1995)
Synchrotron X-ray microscopy reveals early calcium and iron interaction with crocidolite fibers in the lung of exposed mice.
L. Pascolo (2016)
Smoking‐induced iron dysregulation in the lung
W. Z. Zhang (2019)
Pathology of mesothelioma
K. Inai (2008)
Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect.
A. Ghio (2008)
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Florence le Calvez (2005)
Genetic predisposition for malignant mesothelioma: A concise review.
M. Betti (2019)
Molecular basis of asbestos-induced lung disease.
G. Liu (2013)
Erionite exposure in North Dakota and Turkish villages with mesothelioma
M. Carbone (2011)
Understanding relative risk, odds ratio, and related terms: as simple as it can get.
C. Andrade (2015)
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
M. Carbone (2012)
BAP1 links metabolic regulation of ferroptosis to tumor suppression
Yilei Zhang (2018)
Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden
C. Gilham (2015)
This paper is referenced by
MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma
Kyubo Kim (2020)
The Molecular Basis of Malignant Pleural Mesothelioma.
Benjamin Wadowski (2020)
Multiplex Soluble Biomarker Analysis from Pleural Effusion
Joman Javadi (2020)
A critical review of talc and ovarian cancer
J. Goodman (2020)